Estonia Pharmaceuticals & Healthcare Report Q1 2008

Publication Date	February 2008
Publisher	Business Monitor
Product Type	Report
Pages	57
ISBN Number	1748-1872
Product Code	BMI00524

Price

£425.00
approximately: $734 | €540

PDF immediate delivery

Order above formats by FAX

Summary

The Estonian pharmaceutical market is estimated to have reached US$233mn in 2007, rising by 12.5% on the previous year. Key drivers of growth over the next five years will be increased healthcare spending and strong economic growth forecasts, which should push the value of the market to US$331mn by 2012.

Indeed, over the last decade, Estonia has increased its focus on providing public services, with a 10% annual increase in its healthcare spending. Such an investment is urgently needed as poor healthcare has been seen as a weak link in Estonia's 15-year post-Soviet economic 'miracle'. However, the country is still struggling with persistent rates of some infectious diseases, including the highest HIV infection rate in the EU by some distance.

In BMI's revised Business Environment Rankings for the 15 major markets of Central & Eastern Europe (CEE), Estonia is found in a respectable fifth place. However, in absolute terms, Estonia will remain a marginal market in the CEE region. The main limiting factor is the small and falling population, which is compounded by the strict reimbursement regime. On a positive note, the country will continue to invest in biotechnology and pharmaceutical research and development (R&D), which is strongly supported by the government.

In the meantime, imports will continue to gain ground in relation to exports, which have tailed off following the recent winding down of manufacturing, as the largest local firm Tallinn Pharmaceutical Plant - part of Latvia's Grindeks - moved some of its operations abroad. Market expansion is severely limited by strong competition in the supply chain, characterised by a concentrated wholesale market and chain-dominated retail pharmacy landscape.

Content

Executive Summary
Estonia Pharmaceuticals And Healthcare Industry SWOT
Estonia Political SWOT
Estonia Economic SWOT
Estonia Business Environment SWOT
Pharmaceutical Business Environment Ratings
Pharmaceutical Ratings - Revised Methodology
Ratings Overview
Weighting
Estonia - Business Environment Ratings
Limits Of Potential Returns
Risks To Realisation Of Returns
Estonia - Market Summary
Regulatory Regime
Recent Regulatory Developments
Intellectual Property Regime
Pricing Regime
Reimbursement Issues
Recent Pricing And Reimbursement Developments
Industry Developments
Health Profile
Healthcare Sector
Healthcare Funding
Healthcare Insurance
Pharmaceutical Sector
Manufacturing
Wholesale Sector
Retail Pharmacies
Biotechnology
Industry Forecast Scenario
Overall Market Forecast
Key Growth Factors - Industry
Key Growth Factors - Macroeconomic
Prescription Market Forecast
OTC Market Forecast
Generics And Patented Market Forecast
Export/Import Forecasts
Other Healthcare Data Forecasts
Key Risks To BMI's Forecast Scenario
Competitive Landscape
Company Monitor
GlaxoSmithKline
Pfizer
Novartis
Sanofi-Aventis
Merck & Co
Grindeks (includes Tallinn Pharmaceutical Plant)
BMI Forecast Modelling
How We Generate Our Industry Forecasts
Pharmaceutical Industry
Sources
List of Tables
- Table: Pharmaceutical Business Environment Indicators
- Table: Weighting Of Components
- Table: Central And Eastern Europe Pharmaceutical Business Environment Ratings
Table Occurrence Of Malignant Neoplasms in Estonia*
- Table: Recently Approved Generics In Estonia
- Table: Pharmacies And Pharmacy Market Ratios
- Table: Estonia's Drug Market Forecast Expenditure Indicators
- Table: Estonia's Health Expenditure Forecast Indicators
- Table: Estonia - Economic Activity
- Table: Estonia Prescription Drug Market Forecast Indicators (US$mn unless otherwise stated)
- Table: Estonia OTC Market Forecast Indicators (US$mn unless otherwise stated)
- Table: Estonia's Generics And Patented Market Forecast Indicators
- Table: Estonia Pharmaceuticals Exports & Imports Forecasts (US$mn)
- Table: Other Healthcare Data

About this Product

Delivery Details

PDF:Immediate delivery

Ask a question about this product?

Need help finding the right product?

Product features / use

Scope	Expert Insight/Opinion
Level	General Industry Strategies
Data	Detailed Market Forecasts
Profiles	Profiles of Key Companies
Features	Contains SWOT Analysis
Extra Info	Consumer Trends Highlighted